On 5/22/24, CASI Pharmaceuticals Inc (NASDAQ: CASI) stock enjoyed a major increase of 12.0%, closing at $3.46. However, trading volume in this advance was below average at 81% of normal. Relative to the market the stock has been strong over the last nine months and has risen 9.1% during the last week.
Current PriceTarget Research Rating
CASI is expected to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
CASI Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CASI Pharmaceuticals has a poor Appreciation Score of 23 but a slightly positive Power Rating of 65, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment